Tilray Inc - Class 2 (TLRY) Exchange: NASDAQ

Tilray Inc is globally recognized as one of the world’s leading cannabis companies. In 2018, Tilray became the first cannabis-based company to reach the NASDAQ stock exchange and has continued to grow significantly ever since. The company offers a full range of cannabis products including a variety of dried flower, edibles, extracts, and oils that have use cases spanning medical to adult-use. Tilray’s focus is on medical cannabis products, extraction technologies, and scientific research to improve the understanding of cannabis’s beneficial properties. Since its founding, the company has established leading-edge quality control research and testing standards, as well as internal safety processes. Additionally, Tilray is a leader in the research and development of cannabinoid-based treatments. The company operates a major medical cannabis research and production facility in Ontario, Canada as well as multiple business locations around the world, including in the United States, Spain, Australia, New Zealand, Portugal, and South Africa. In 2019, Tilray and Anheuser-Busch InBev announced the launch of an exclusive partnership to research cannabis and non-alcoholic beverages. The company employs thousands of people in 22 countries and produces products in seven countries. Most recently, Tilray announced the acquisition of Natura Naturals, one of Canada’s fastest-growing Licensed Producers of medical and adult-use cannabis. This was a major milestone for the company, as the acquisition provides Access to Natura Naturals’ production and processing capabilities and strengthens Tilray’s ability to compete as a global leader in the cannabis industry.